2026-04-29T15:25:25Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/149282025-05-26T14:58:27Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19619

00925njm 22002777a 4500 dc Mínguez Clemente, P author Pascual-Carrasco, Mario author Mata Hernández, C author Malo de Molina, Rosa author Arvelo, L A author Cadavid, B author López Grondona, Fermín author Sánchez-de-Madariaga, Ricardo author Sam, A author Trisan Alonso, A author Valle Falcones, M author Aguilar Pérez, M author Muñoz Carrero, Adolfo author Pérez de la Cámara, Santiago author Burgos Llamo, Alfredo author López Viña, A author Ussetti Gil, P author 2021-02 The results reported by different studies on telemonitoring in patients with chronic obstructive pulmonary disease (COPD) have been contradictory, without showing clear benefits to date. The objective of this study was to ascertain whether an early discharge and home hospitalization telehealth program for patients with COPD exacerbation is as effective as and more efficient than a traditional early discharge and home hospitalization program. A prospective experimental non-inferiority study, randomized into two groups (telemedicine/control) was conducted. The telemedicine group underwent monitoring and was required to transmit data on vital constants and ECGs twice per day, with a subsequent telephone call and 2 home visits by healthcare staff (intermediate and at discharge). The control group received daily visits. The main variable was time until first exacerbation. The secondary variables were: number of exacerbations; use of healthcare resources; satisfaction; quality of life; anxiety-depression; and therapeutic adherence, measured at one and 6 months of hospital discharge. A total of 116 patients were randomized (58 to each group) without significant differences in baseline characteristics or time until first exacerbation, i.e. median 48 days (pp. 25-75:23-120) in the control group, and 47 days (pp. 25-75:19-102) in the intervention group; p = 0.52). A significant decrease in the number of visits was observed in the intervention versus the control group, 3.8 ± 1 vs 5.1 ± 2(p = 0.001), without significant differences in the number of exacerbations. In conclusion follow-up via a telemedicine program in early discharge after hospitalization is as effective as conventional home follow up, being the cost of either strategy not significantly different. COPD. 2021 Feb;18(1):62-69. 10.1080/15412555.2020.1857717 1541-2563 COPD: Journal of Chronic Obstructive Pulmonary Disease 33307857 http://hdl.handle.net/20.500.12105/14928 COPD Early discharge Home hospitalization Telemonitoring Follow-up with Telemedicine in Early Discharge for COPD Exacerbations: Randomized Clinical Trial (TELEMEDCOPD-Trial)